BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9286734)

  • 1. Follicular development and oocyte maturation in hypogonadotrophic women employing recombinant follicle-stimulating hormone: the role of oestradiol.
    Fauser BC
    Hum Reprod Update; 1997; 3(2):101-8. PubMed ID: 9286734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
    Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
    Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys.
    Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
    Hum Reprod; 1995 Jul; 10(7):1658-66. PubMed ID: 8582957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone.
    Fleming R; Lloyd F; Herbert M; Fenwick J; Griffiths T; Murdoch A
    Hum Reprod; 1998 Jul; 13(7):1788-92. PubMed ID: 9740424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens.
    Devroey P; Mannaerts B; Smitz J; Coelingh Bennink H; Van Steirteghem A
    Hum Reprod; 1994 Jun; 9(6):1064-9. PubMed ID: 7962377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant FSH-induced follicle development in immature rats treated with an LHRH antagonist:a direct effect of RU486 on follicular atresia.
    Uilenbroek JT; Kramer P; van Leeuwen EC; Karels B; Timmerman MA; de Jong FH; de Leeuw R
    J Endocrinol; 1996 Jul; 150(1):85-92. PubMed ID: 8708566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant luteinizing hormone as a survival and differentiation factor increases oocyte maturation in recombinant follicle stimulating hormone-supplemented mouse preantral follicle culture.
    Cortvrindt R; Hu Y; Smitz J
    Hum Reprod; 1998 May; 13(5):1292-302. PubMed ID: 9647562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human gonadotrophins on oocyte meiosis and steroidogenesis in isolated pre-ovulatory rat follicles.
    Törnell J; Bergh C; Selleskog U; Hillensjö T
    Hum Reprod; 1995 Jun; 10(6):1619-22. PubMed ID: 7593545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
    Teissier MP; Chable H; Paulhac S; Aubard Y
    Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
    Schoot DC; Coelingh Bennink HJ; Mannaerts BM; Lamberts SW; Bouchard P; Fauser BC
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1471-3. PubMed ID: 1592896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of luteinizing hormone and follicle stimulating hormone on the developmental competence of porcine preantral follicle oocytes grown in vitro.
    Wu J; Xu B; Wang W
    J Assist Reprod Genet; 2007 Sep; 24(9):419-24. PubMed ID: 17636438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folliculogenesis in hypophysectomized rats after treatment with recombinant human follicle-stimulating hormone.
    Mannaerts B; Uilenbroek J; Schot P; De Leeuw R
    Biol Reprod; 1994 Jul; 51(1):72-81. PubMed ID: 7918877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the luteinizing hormone-releasing hormone agonist, deslorelin, on patterns of estradiol-17 beta and luteinizing hormone secretion, ovarian follicular responses to superstimulation with follicle-stimulating hormone, and recovery and in vitro development of oocytes in heifer calves.
    Maclellan LJ; Bergfeld EG; Earl CR; Fitzpatrick LA; Aspden WJ; Kinder JE; Walsh J; Trigg TE; D'Occhio MJ
    Biol Reprod; 1997 Apr; 56(4):878-84. PubMed ID: 9096868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of oestradiol for follicular development in hypogonadotrophic immature rats treated with FSH and hCG.
    Uilenbroek JT; Kramer P; Karels B; de Jong FH
    J Reprod Fertil; 1997 Jul; 110(2):231-6. PubMed ID: 9306975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.